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Hormones and Dietary Fat as Promoters
in Mammary Carcinogenesis
by Thomas L. Dao* and Po-Chuen Chan*
Hormones, particularly ovarian steroids and pituitary prolactin, promote mammary carcinogene-
sis in rats treated with a carcinogen. Hormones also play a critical role during the initiation process
as demonstrated by mammary carcinogenesis in ovariectomized rats. A diet high in fat content, es-
pecially polyunsaturated fat, promotes mammary tumorigenesis when it is fed to carcinogen-treated
rats for a prolonged period of time. Although a high fat diet is not essential for neoplastic transfor-
mation of the mammary cells, its effect on initiation is demonstrated when it is fed to rats for a long
duration. Thus, both hormones and high dietary fat play a dual function in mammary carcinogene-
sis. There are indications that dietary fat may modulate endocrine activities, but a relationship be-
tween dietary fat and endocrine function remains to be conclusively demonstrated.
Introduction
This paper presents an overview of the role of
hormones and dietary fat as tumor promoters in
mammary carcinogenesis in the rat. Several infor-
mative reviews on this subject have been published
(1,2). To state that hormones, particularly the ster-
oidal estrogens, and dietary fat are mere tumor pro-
moters is an oversimplification at best. The critical
role of ovarian hormones in the initiation of mam-
mary carcinogenesis by a chemical carcinogen has
been reported earlier (3). The working hypothesis
that hormones, particularly the estrogens, play a
dual function in mammary carcinogenesis is as valid
today as it was when first suggested by Dao (4)
about a decade and a half ago.
Similarly, the concept that a high fat diet en-
hances mammary carcinogenesis merely by its pro-
motional effect can be challenged. Recent experi-
ments from our laboratory strongly suggest that
the enhancing effect of dietary fat on mammary tu-
morigenesis is proportional to the duration of time
for which the rats are on the high fat diet, irrespec-
tive of whether the high fat diet is given before or
after the carcinogen treatment (5).
These observations on the effects of hormones or
a high fat diet clearly suggest that hormones or a
high fat diet are important cofactors modulating not
only the initiation process but also the expression of
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transformed cells to form tumors and the rate of
subsequent tumor growth. It is suggested that in-
vestigations must be directed toward examining the
possible interactions between the carcinogen and
hormones and between the carcinogen and dietary
fat in both the initiation and promotion of mammary
carcinogenesis. It is this perception that leads us to
look first at a possible relationship between dietary
fat and endocrine functions in the induction of mam-
mary tumors by a chemical carcinogen.
Tumor Promotion in the Mammary
Gland by Hormones
The best examples of tumor promotion by hor-
mones are experiments designed to study the ef-
fects of pregnancy and the effects of ovariectomy on
mammary carcinogenesis in the rat.
Effects ofPregnancy
The study of the effects of pregnancy in the in-
duction of mammary tumors by a chemical carcino-
gen demonstrated, perhaps for the first time, the
possible presence of a two-stage mechanism in mam-
mary carcinogenesis. Dao and Sunderland (6) re-
ported that in rats previously treated with a chemi-
cal carcinogen, such as 3-methylcholanthrene (3-
MCA), pregnancy greatly accelerated the appear-
ance and incidence of mammary tumors. Figure 1 is
a schematic diagram based on data published ear-
lier to illustrate the effect of pregnancy on the pro-
motion of mammary tumorigenesis by 3- methylcho-DAO AND CHAN
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FIGURE 1. Promoting effect of pregnancy in mammary
carcinogenesis by 3-methylcholanthrene in Sprague-
Dawley rats.
lanthrene. The dose used in these two sets of exper-
iments was 10 mg 3-MCA daily for 6 or 10 days ad-
ministered by intragastric intubation. Rats were
then mated 4 days after the last dose of the carcino-
gen. The results clearly show that pregnancy after
the administration of a chemical carcinogen induced
a significant increase in tumor incidence, a greatly
shortened latent period and a marked increase in
the number of tumors developed. Thus, whereas 3-
MCA given at 10 mg daily for 6 days induced a tu-
mor incidence of only 10%, the same dose of the
carcinogen caused a marked rise of tumor incidence
to 50% with a latent period of 40 days, if the rats
became pregnant after carcinogen treatment. Simi-
lar results were seen in rats given a higher dose (10
mg x 10) of 3-MCA. Again, one sees a significant
increase in tumor incidence and greatly shortened
latent period as a result of pregnancy. It is inter-
esting to note that the latent period of tumor ap-
pearance was practically the same in all the preg-
nant groups, irrespective of the dose of carcinogen.
Also, as the time between pregnancy and the last
dose of the carcinogen increased, the latent period
was further shortened (expt. V, Fig. 1). Parturi-
tion brought about a rapid regression of tumor
growth, but subsequent pregnancy regularly led to
the regrowth of these regressing tumors (6). Alto-
gether, these experiments demonstrate the greatly
increased hormonal activity during pregnancy that
is a complex interaction of steroidal and polypeptide
hormones and is the cause of the greatly acceler-
ated tumor growth, since these tumors all regress
after parturition.
The effect of pregnancy on tumor promotion,
however, was abolished when the carcinogen was
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FIGURE 2. Relationship between time elapsed after car-
cinogen treatment and mammary tumor promotion by
pregnancy in Sprague-Dawley rats.
given to rats that were already pregnant. Thus, if 3-
MCA, irrespective of dose (10 mg x 6, or 10 mg x
10), was given to female pregnant rats, mammary
tumor induction was partially or totally inhibited
(6,7). This failure to enhance tumor induction in rats
fed 3-MCA during pregnancy suggests at least that
an initiation process for induction of "latent tumor
cells" by the carcinogen is necessary. This conclu-
sion can be further substantiated by experiments
using a single feeding of 3-MCA to female rats; at
different time intervals these carcinogen-treated
rats were mated and pregnancy ascertained. The
results disclosed in Figure 2 conclusively show that
pregnancy immediately following carcinogen admin-
istration appears to inhibit carcinogenesis. How-
ever, as the time interval between carcinogen treat-
ment and pregnancy increased, mammary tumor in-
cidence rose. This experiment clearly demonstrates
the critical significance of the time between initia-
tion and promotion in carcinogenesis. It is interest-
ing to note that in these pregnant groups, if tumors
developed, they appeared before parturition. It
should be pointed out also that the failure of the
carcinogen to induce mammary tumors in pregnant
rats may also be due to an as yet unelucidated fac-
tor that pregnancy induces cellular changes in the
mammary gland, rendering it resistent to the effect
of a carcinogen.
Effect of Ovarian Hormones on Mammary
Tumorigenesis in Ovariectomized Rats
The other experiment that demonstrates the pro-
moting effect of hormones is the induction of mam-
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mary tumors by a chemical carcinogen in ovariecto-
mized rats. It is suggested that if ovarian hormones
are essential for initiation of malignant transforma-
tion of mammary cells, a chemical carcinogen given
to a castrated female rat will be unable to induce
the development of mammary tumors, even if ovar-
ian hormones are given later on. In contrast, one
would expect mammary tumor development in
these castrated and carcinogen-treated rats after
treatment with ovarian hormones, if the hormonal
effect is promotional. The experiments were there-
fore designed to investigate whether ovarian hor-
mones are of critical importance in tumor initiation
or whether they are merely tumor promoters. The
experiment involved seven groups of rats. After
oral feeding of a 10-mg dose of 7,12- dimethylbenz(a)
anthracene (7,12-DMBA) to all animals, group 1 was
kept as a control throughout the experiment, and
groups 2-7, each containing twenty 55-to-60-day-old
female Sprague-Dawley rats, were castrated at in-
tervals of 1, 3, 7, 15, 20 and 30 days, respectively. At
40-50 days after DMBA feeding, 10 rats from each
group received a pair of ovarian grafts, and the
other half of the animals served as controls. The
rats in all these experiments were examined weekly
for tumors. The experiments were terminated at
the end of 6-8 months. At autopsy, tumors and
ovarian grafts were excised and were fixed for his-
tological sections.
The results summarized in Figure 3 show that
the removal of ovaries immediately after the admin-
istration of 10 mg DMBA reduced the incidence of
mammary cancer. The data clearly demonstrate
that the incidence of mammary tumors depends on
the time of interaction between ovarian hormones
and the carcinogen-treated gland. The longer the
duration, the greater is the neoplastic transforma-
tional and tumor development. Thus, castration
20-30 days after DMBA treatment had no effect on
neoplastic transformation and tumor incidence,
since later transplantation of a pair of functioning
ovaries caused the development of the mammary
tumors, with an incidence comparable to that of the
controls.
Studies reported earlier by Dao (3,8) using male
rats and with a similar experimental design dis-
closed that when castrated male rats bearing func-
tional ovarian grafts were treated with a single
dose of 3-MC, mammary tumors were induced in
65% of the rats so treated. If, however, the carcino-
gen was given to the castrated rats first and ova-
ries were transplanted 30 days later, the tumor inci-
dence was only 10%. Altogether, these experiments
give convincing evidence that the presence of ovar-
ian hormones was a prerequisite for neoplastic
transformation of the mammary cells exposed to a
ioor
w
O) CONTROL (INTACT)
Z 70
Z 60_
cr OVARIAN GRAFT->
0 40-50 DAYS AFTER DMBA
50
z 40
w
W 30-
20 /X
10
OMBA
1 3 5 7 9 11 13 15 17 19 21
DAYS (CASTRATION AFTER DMBA)
FIGURE 3. Mammary tumorigenesis in ovariectomized rats.
See text for experimental procedure.
chemical carcinogen, since no mammary tumors ap-
peared later even when the source of the ovarian
hormones was restored.
Tumor Promotion in Mammary
Carcinogenesis by Dietary Fat
The effect of high dietary fat on the development
of spontaneous mammary tumors was reported
more than three decades ago by Tannenbaum (9).
Recent epidemiologic studies have led to a burst of
investigation to examine the relationship between
dietary fat and mammary tumors in experimental
models. Thus, several investigators have reported
that spontaneous, chemically or radiation-induced
mammary tumors appeared early and in greater
numbers in rats fed a high-fat diet compared to
those fed a low-fat diet (10-12). Carroll and Khor
further reported that enhancement of mammary tu-
mor development was observed only in rats fed a
high fat diet after but not before DMBA treatment
(13). These authors concluded that a high-fat diet ex-
erts its effect only during the promotional phase of
mammary carcinogenesis. Subsequent investiga-
221DAO AND CHAN
tions by others (14) largely using a similar experi-
mental design appear to agree with the conclusion
that high dietary fat promotes mammary tumor
growth. Unfortunately, these conclusions were de-
rived from experiments that were inadequately de-
signed to study the role of dietary fat in mammary
carcinogenesis. Careful examination of all these re-
ported experiments, however, reveals at least one
common deficiency in their experimental design. In
all these studies, particularly those involving
feeding a high-fat diet before carcinogen administra-
tion, the duration of feeding of the high-fat diet is
often three to four times longer in rats receiving
the high-fat diet after the carcinogen treatment
than in those given the same diet before carcinogen
administration. This enormous difference in the di-
etary fat intake is probably the major reason for
the "erroneous" conclusion that the high-fat diet had
no effect if given prior to carcinogen treatment. Re-
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FIGURE 4. Relationship between mammary tumor incidence
and duration of a high-fat diet feeding in female Fischer
rats given N-methylnitrosourea at 50 days of age. Each
group of rats was fed a high-fat diet for the duration of
time indicated; otherwise, they were fed a low-fat diet.
cent investigations from our laboratory disclosed re-
sults that strongly suggest that the tumor incidence
in rats receiving the high-fat diet is a function of
the duration of the high-fat diet feeding (5). Figure
4 demonstrates that mammary tumor incidence is
positively correlated with the total timre period of
high-fat ingestion.
The efficacy of dietary fat in the enhancement of
mammary tumorigenesis appears to be related to
the amount of essential fatty acids in the dietary
fat, as reported by Carroll and Khor (15). Saturated
fats such as tallow and coconut oil do not contain
sufficient essential fatty acids to support normal
growth. Mammary carcinogenesis is reduced in rats
fed diets containing these fats. But when 3% sun-
flower seed oil is added to a high-fat diet containing
17% coconut oil and fed to experimental rats, the
diet enhances mammary carcinogenesis just as ef-
fectively as a high-fat diet containing 20% sunflow-
er seed oil. These authors concluded that once the
requirements for essential fatty acids are met, the
total amount of fat intake, not the type of fat, is cru-
cial in mammary tumor promotion (16). In contrast,
we compared mammary carcinogenesis by NMU in
four groups of Fischer rats fed a high-fat diet con-
taining 32% corn oil, lard, coconut oil, or beef tallow
supplemented with 1% corn oil. Mammary tumor
incidence was significantly higher in rats fed the
corn oil and lard diets than in rats fed the coconut
and beef tallow diets (Table 1). Rogers and Wetsel
(17) reported that a diet containing 30% beef tallow
+ 2% vegetable oil retarded mammary carcinogen-
esis by N-2-fluorenylacetamide (AAF) or DMBA,
compared to a diet containing 15% vegetable oil.
King et al. (18) demonstrated that mammary tumor
incidence was lower in rats fed a diet containing
18% stripped hydrogenated coconut oil + 2% lino-
leic acid compared to rats on a 20% stripped corn
oil diet. In the latter three experiments, there were
sufficient amounts of essential fatty acids in the di-
ets, yet rats on these diets exhibited reduced mam-
mary tumor yield. Further studies are required to
define whether the total amount of dietary fat or
the type of fat is more important in mammary carci-
nogenesis.
Table 1. Mammary tumor incidence in Fischer rats fed different types of dietary fat.
Mammary tumor
No. ofrats incidence,
Group Diet at risk % No. oftumors/rat
1 Corn oil 26 85% 1.5
2 Lard 27 63% 1.0
3 Beeftallow 30 50% 0.8
4 Coconut oil 23 43% 0.6
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Relationship between Dietary Fat
and Endocrine Functions
The possible modulation of endocrine functions
by high dietary fat has been proposed by several in-
vestigators and data on the effect of a high fat diet
on the levels of several hormones, including
prolactin and estrogen, have been reported (11, 19-
21). What is not clearly understood is the rationale
or the conceptual basis for the suggestion that high
dietary fat may modulate endocrine activities as the
possible mechanism by which it enhances mammary
tumorigenesis. However, since the effect of a high-
fat diet is considered to be "promotional" and since
hormones are known to be the key "promoting
agents" of mammary tumor growth (22), it appears
reasonable to suggest that the mechanism by which
the high-fat diet enhances mammary carcinogenesis
may indeed be the modulation of endocrine func-
tions.
Effect of a High-Fat Diet on Serum
Prolactin
Chan et al. (23) reported earlier that afternoon se-
rum prolactin levels were significantly higher in
proestrus rats on a high-fat diet than in rats on a
low-fat diet. A paper published later by Ip et al. (21)
reported that in rats with median eminence lesion,
high-fat diets caused a significantly increased inci-
dence of mammary tumors compared to those on a
low-fat diet. The results suggested that prolactin
was not a factor in enhancing mammary tumors in
rats receiving a high-fat diet, since median emi-
nence lesion induces elevated serum prolactin which
is constant and not affected by other endocrine ma-
nipulations. Yet in the same paper, in sham-oper-
ated rats, a high-fat diet not only caused increased
tumor incidence but also higher serum levels of pro-
lactin than in those receiving the low-fat diet.
These conflicting results were not convincingly
explained.
The other indirect evidence suggesting a
relationship between a high-fat diet and prolactin is
the observation that enhancement of mammary tu-
morigenesis in rats fed a high-fat diet can be
blocked by the administration of an ergot drug (CB-
154) (24). It is known that ergot compounds inhibit
prolactin secretion and reduce serum prolactin
levels by probably both a direct effect on the
pituitary and by increasing hypothalamic prolactin
inhibiting factor.
The relationship between dietary fat and
prolactin in mammary carcinogenesis is dubious at
best. Recently, Hopkins et al. reported a lack of dif-
ference in serum prolactin levels in rats fed a high-
fat or low-fat diet (25). In all the above experiments,
often only a single blood sample during the entire
estrous cycle was assayed. These authors ignored
the episodic fluctuations of prolactin levels and also
the changes during the estrous cycles. Thus, data
obtained from assay of a single blood sample at the
end of the experimental period can hardly be valid
for any meaningful interpretations. A carefully de-
signed experiment is imperative to elucidate the
possible influence of dietary fat on pituitary
prolactin.
Effect of a High-Fat Diet on Serum
Estrogens
Since prolactin synthesis and secretion by the pi-
tuitary is partially regulated by estrogen, the effect
of the dietary fat on estrogen synthesis and
secretion was investigated by Chan et al. (11). These
authors reported that tumor-bearing rats on a high-
fat diet have a slightly higher serum estrogen level
than rats on a low-fat diet. Later, in our laboratory
Ip observed that serum estrogen levels appeared to
reflect the amount of fat in the diet (20). The data in
both these experiments were again based on one
single blood sample taken at the end of the ex-
periment. Blood samples taken at regular intervals
throughout a complete estrous cycle at varying
time periods during the experiment may give a
better picture of the effects of dietary fat on serum
estrogen levels.
Indirect evidence suggesting a possible
relationship between a high-fat diet and ovarian
function was reported by Frisch et al. (26), who
observed early vaginal opening and estrus in rats
on a high-fat diet. This observation was confirmed
by others (18) and led to the conclusion that a high-
fat diet has an effect on ovarian function.
Discussion and Conclusion
Although hormones, particularly the ovarian
hormones estrogen and progesterone, and the
pituitary prolactin clearly play a major role in the
promotion of mammary tumorigenesis induced by a
chemical carcinogen, experimental results are
equally convincing that the estrogenic hormone is
critically needed for the initiation of neoplastic
transformation of mammary cells. Our data disclose
that mammary tumors do not develop if estrogen is
absent during the initiation of neoplastic trans-
formation by a carcinogen. Estrogen may act in a
specific way to enhance the response of the in-
teraction between the carcinogen and the target
tissue in the initiation of carcinogenesis. Ovarian
hormones play a dual function in mammary car-
cinogenesis.
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The effect of dietary fat in mammary carcinogene-
sis, whether it is primarily tumor-promoting, re-
mains tobe investigated. The conclusion that high di-
etary fat only plays a role of a tumor promoter must
be challenged, since the data are neither convincing
nor properly interpreted. Earlier studies by Carroll
and Khor (2) disclosed that a high-fat diet fed to rats
4 weeks after carcinogen treatment was unable to
"promote" tumor growth. These authors reported
that a high-fat diet was effective in enhancing
mammary tumorigenesis only ifit was given within 2
weeks of carcinogen treatment. These data are
perplexing, in view of the data from studies of both
mammary gland and skin carcinogenesis, which
indicate that the tumor- promoting effect of hor-
mones and croton oil (phorbol esters) could be
demonstrated long after the administration of the
carcinogen (27,28). If a high-fat diet is indeed a
promoter, one would expect mammary tumor
development, even ifthe high-fat diet was fed to rats
longafter carcinogen treatment.
Recent studies in our laboratory conclusively
show that the mammary tumor yield in rats fed a
high-fat diet was directly proportional to the time
period of high-fat feeding. The longer the rats were
fed a high-fat diet, the higher the mammary tumor
incidence (15). This explains why enhancement of
mammary carcinogenesis is more pronounced
during the "promotional" phase as the rats were fed
a high-fat diet continuously for a prolonged period
of time until the end of the experiments. When the
rats were fed a high-fat diet before carcinogen
treatment, the maximal feeding duration was a 4-
week period, since the experimental protocol calls
for administration of the carcinogen at 50 days of
age. In our experiments, when we fed rats a high-
fat diet for 4 weeks after the carcinogen treatment,
we failed to observe an increase in mammary tumor
incidence in these rats compared to those rats fed a
low-fat diet. Further experiments are required to
clarify the mode of action of a high-fat diet in the
enhancement of mammary carcinogenesis.
Although indirect evidence has been observed to
suggest a relationship between a high-fat diet and
endocrine functions, the data reported so far are un-
convincing and confusing.
It must be noted that the role of prolactin, estro-
gen and progesterone in mammary carcinogenesis
is interrelated; measurement of serum levels of
these hormones will not elucidate the mechanism by
which a high-fat diet affects mammary carcinogene-
sis. The biosynthesis of estrogen and progesterone
in rats fed a high-fat diet must be investigated.
Equally important is the study to determine
whether the effects of a high-fat diet in mammary
carcinogenesis are mediated via neuroendocrine
mechanisms.
REFERENCES
1. Dao, T. L. Studies on the mechanism of carcinogenesis in
the mammary gland. In: Progress in Experimental Tumor
Research, Vol. 11 (F. Homburger, Ed.), S. Karger, Basel/
New York, 1969, pp. 235-261.
2. Carroll, K. K., and Khor, H. T. Dietary fat in relation to
tumorigenesis. In: Progress in Biochemical Pharmacology,
Vol. 10. Karger, Basel, 1975, pp. 308-353.
3. Dao, T. L. The role of ovarian hormones in initiating the
induction of mammary cancer in rats by polycyclic hydro-
carbons. Cancer Res. 22: 973-981 (1962).
4. Dao, T. L. The dual function of hormones in mammary
carcinogenesis: A working hypothesis. In: On Cancer and
Hormones, University of Chicago Press, Chicago, 1962,
pp. 231-241.
5. Chan, P. C., and Dao, T. L. A high fat intake increased
mammary gland susceptibility to carcinogenesis. Proc.
Am. Assoc. Cancer Res. 22: 448 (1981).
6. Dao, T. L., and Sunderland, H. J. Mammary car-
cinogenesis by 3-methylcholanthrene. I. Hormonal aspects
in tumor induction and growth. J. Natl. Cancer Inst. 23:
567-585 (1959).
7. Dao, T. L., Bock, F. G., and Greiner, M. J. Mammary
carcinogenesis by 3-methylcholanthrene. II. Inhibitory
effect of pregnancy and lactation on tumor induction. J.
Natl. Cancer Inst. 25: 991-1003 (1960).
8. Dao, T. L., and Greiner, M. J. Mammary carcinogenesis
by 3-methylcholanthrene. III. Induction of mammary car-
cinogenesis and milk secretion in male rats bearing ovar-
ian grafts. J. Natl. Cancer Inst. 27: 333-349 (1961).
9. Tannenbaum, A. The genesis and growth of tumors. III.
Effects of a high-fat diet. Cancer Res. 2: 468-475 (1942).
10. Carroll, K. K. Experimental evidence of dietary factors
and hormone-dependent cancers. Cancer Res. 35:
3374-3383 (1975).
11. Chan, P. C., Head, J. F., Cohen, L. A., and Wynder, E. L.
Influence of dietary fat on the induction of mammary tu-
mors by N-nitrosomethylurea: associated hormone
changes and difference between Sprague-Dawley and
F344 rat. J. Natl. Cancer Inst. 59: 1279-1283 (1977).
12. Silverman, J., Shellabarger, C. J., Holtzman, S., Stone,
J. P., and Weisburger, J. H. Effect of dietary fat on X-ray-
induced mammary cancer in Sprague-Dawley rats. J.
Natl. Cancer Inst. 64: 631-634 (1980).
13. Carroll, K. K., and Khor, H. T. Effects of dietary fat and
dose levels of 7,12-DMBA on mammary cancer incidence
in rats. Cancer Res. 30: 2260-2264 (1970).
14. Hopkins, G. J., West, C. E., and Hard, G. C. Effect of di-
etary fat on the incidence of 7,12-dimethylbenz(a)anthra-
cene-induced tumors in rats. Lipids 11: 328-333 (1976).
15. Carroll, K. K., and Khor, H. T. Effects of level and type of
dietary fat on the incidence of mammary tumors induced
in female Sprague-Dawley rats by 7,12-dimethylbenz(a)an-
thracene. Lipids 6: 415-420 (1970).
16. Hopkins, G. J., and Carroll, K. K. Relationship between
amount and type of dietary fat in promotion of mammary
carcinogenesis induced by 7,12-dimethylbenz(a)anthra-
cene. J. Natl. Cancer Inst. 62: 1009-1012 (1979).
17. Rogers, A. E., and Wetsel, W. C. Mammary carcinogene-
sis in rats fed different amounts and type of fat. Cancer
Res. 41: 3735-3737 (1981).
18. King, M. M., Bailey, D. M., Gibson, D. D., Pitha, J. V., and
McCay, P. B. Incidence and growth of mammary tumors
induced by 7,12-dimethylbenz(a)anthracene as related to
the dietary content of fat and antioxidant. J. Natl. Cancer
Inst. 63: 657-663 (1979).
19. Chan, P. C., and Cohen, L. A. Dietary fat and growthHORMONES AND DIETARYFATIN CARCINOGENESIS 225
promotion of rat mammary tumors. Cancer Res. 35:
3384-3386 (1975).
20. Ip, C., and Ip, M. M. Serum estrogens and estrogen re-
sponsiveness in 7,12-dimethylbenz(a)anthracene-induced
mammary tumors as influenced by dietary fat. J. Natl.
Cancer Inst. 66: 291-295 (1981).
21. Ip, C., Yip, P., and Bernardis, L. L. Role of prolactin in the
promotion of dimethylbenz(a)anthracene-induced mamma-
ry tumors by dietary fat. Cancer Res. 40: 374-378 (1980).
22. Sinha, D., Cooper, D., Dao, T. L. The nature of estrogen
and prolactin effect on mammary tumorigenesis. Cancer
Res. 33: 411-414 (1973).
23. Chan, P. C., Didato, F., and Cohen, L. A. A high dietary
fat, elevation of rat serum prolactin, and mammary can-
cer. Proc. Soc. Exp. Biol. Med. 149: 133-135 (1975).
24. Chan, P. C., and Cohen, L. A. Effect of dietary fat, anties-
trogen, and antiprolactin on the development of mam-
mary tumors in rats. J. Natl. Cancer Inst. 52: 25-30
(1974).
25. Hopkins, G. J., Kennedy, T. G., and Carroll, K. K. Polyun-
saturated fatty acids as promoters of mammary car-
cinogenesis induced in Sprague-Dawley rats by 7,12-di-
methylbenz(a)anthracene. J. Natl. Cancer Inst. 66:
517-522 (1981).
26. Frisch, R. E., Hegsted, D. M., and Yoshinaga, K. Body
weight and food intake at early estrus of rats on a high-fat
diet. Proc. NatI. Acad. Sci. (U.S.) 72: 4172-4176 (1975).
27. Dao, T. L. Carcinogenesis of mammary gland in rat. Prog.
Exp. Tumor Res. 5:157-216 (1964).
28. Boutwell, R. K. Some biological aspects of skin car-
cinogenesis. Prog. Exptl. Tumor Res. 4: 207-250 (1964).